Line 77: | Line 77: | ||
<center> | <center> | ||
<a href="/Team:Tongji_China/Model"><button class="homePageButton"style="background-color:#98B2D2;">Dry Lab</button></a> | <a href="/Team:Tongji_China/Model"><button class="homePageButton"style="background-color:#98B2D2;">Dry Lab</button></a> | ||
− | <a href="/Team:Tongji_China/WetLab"><button class="homePageButton"style="background-color:#EEC778;">Wet Lab</button></a><br> | + | <a href="/Team:Tongji_China/WetLab"><button class="homePageButton"style="background-color:#EEC778;">Wet Lab</button></a><br><br> |
<a href="/Team:Tongji_China/Safety"><button class="homePageButton"style="background-color:#A8A96B;">Safety</button></a> | <a href="/Team:Tongji_China/Safety"><button class="homePageButton"style="background-color:#A8A96B;">Safety</button></a> | ||
</center> | </center> |
Revision as of 10:32, 17 October 2018
Welcome to
Tongji_China
We focus our attention on
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
We use the bioinformatic method
to filter our item antigens and
use the T3SS in P. aeruginosa to deliver
them to the T cells through
oral intake.
to filter our item antigens and
use the T3SS in P. aeruginosa to deliver
them to the T cells through
oral intake.
We filter the antigens of interest.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.